Broadcom US11135F1012 Broadcom Inc. is sending mixed messages to investors at the start of the year. While institutional analysts project significant long-term growth, actions by the company's own leadership are introducing near-term uncertainty. A multimillion-dollar stock disposal by Chief Financial Officer Kirsten M. Spears has become a focal point for market concern, prompting a debate over wh...
Broadcom US11135F1012 Broadcom Inc. is sending mixed messages to investors at the start of the year. While institutional analysts project significant long-term growth, actions by the company's own leadership are introducing near-term uncertainty. A multimillion-dollar stock disposal by Chief Financial Officer Kirsten M. Spears has become a focal point for market concern, prompting a debate over whether this represents a routine portfolio adjustment or a more cautionary signal. The recent share price weakness follows a transaction disclosed in SEC filings dated January 5. The documents reveal that CFO Kirsten M. Spears sold 30,000 Broadcom shares on December 31 at an average price of $347.82. This disposal, valued at approximately $10.4 million, reduced her direct holdings by nearly 10%. Market participants reacted to this news by taking profits, coming after a remarkable 12-month rally that saw the stock appreciate by roughly 50%. The decline below the $345 level reflects short-term investor unease, even though insider selling following such a powerful advance is not uncommon. On the institutional side, however, support remains robust. Bank of America reiterated its Buy rating this week, naming Broadcom alongside Nvidia and AMD as a top semiconductor pick for 2026. The bank's analysts characterized the current pullback as a technical correction rather than a reflection of deteriorating fundamentals. They highlighted Broadcom's commanding position in Ethernet networking for AI data centers and its custom chip (ASIC) business as primary growth drivers. Concurrently, the ongoing CES 2026 in Las Vegas, where AI infrastructure is a central theme, continues to generate investor interest in key hardware suppliers. Strong Fundamentals Underpin the Long-Term View The optimistic institutional stance is grounded in solid recent financial performance. For its fourth fiscal quarter, the company reported revenue of $18.02 billion, surpassing market expectations. More critical for...
AMD has shown off its next-gen and the world's first 2nm EPYC Venice "Zen 6" CPU & Instinct MI455X, designed for Helios AI Racks. AMD Dives Into The 2nm Era With Next-Gen EPYC Venice "Zen 6" CPU & Instinct MI455X GPU, Built For Helios AI Rack AMD has finally shown off the world's first 2nm chips, which will power its next-generation AI capabilities on the Helios AI Rack. The Helios AI rack was fir...
AMD has shown off its next-gen and the world's first 2nm EPYC Venice "Zen 6" CPU & Instinct MI455X, designed for Helios AI Racks. AMD Dives Into The 2nm Era With Next-Gen EPYC Venice "Zen 6" CPU & Instinct MI455X GPU, Built For Helios AI Rack AMD has finally shown off the world's first 2nm chips, which will power its next-generation AI capabilities on the Helios AI Rack. The Helios AI rack was first unveiled at the most recent Financial Analyst Day 2025, and the company promised some big performance figures with class-leading numbers and efficiency for AI workloads. 2 of 9 The Helios rack is a fully liquid-cooled design that features four Instinct MI455X GPUs and a single EPYC Venice "Zen 6" CPU. The system leverages AMD's Pensando "Salina" 400 DPU, & the Pensando "Vulcano" 800 AI NIC for networking and interconnection. Each AMD EPYC Venice "Zen 6" CPU comes with up to 256 cores based on the Zen 6C architecture, and each Instinct MI455X GPU packs several thousand compute units. The Helios rack scales up to 2.9 Exaflops of AI compute, 31 TB of HBM4 memory, 43 TB/s of scale-out bandwidth, and up to 4600 CPU + 18,000 GPU cores. Besides the rack and tray details, AMD CEO, Dr. Lisa Su, held the company's and the world's first 2nm chips. The MI455X GPU comes with two massive GCD (Graphics Compute Dies), two MCD (Memory Controller Dies), and a total of 16 HBM4 sites. The chip is as massive as it gets. As per previous information, the MI450X AI accelerators will feature 40 PFLOPs of FP4, 20 PFLOPs of FP8 compute performance, 432 GB of HBM4 memory with up to 19.6 TB/s bandwidth per chip, 3.6 TB/s scale-up, and 300 GB/s scale-out bandwidth. AMD has positioned its Instinct MI400 GPUs against NVIDIA's Vera Rubin, and the high-level comparison looks something like the following: 1.5x Scale-Out Bandwidth vs Competition 1.5x Memory Capacity vs Competition Same Memory Bandwidth vs Competition Same FP4 / FP8 FLOPs vs Competition Same Scale-Up Bandwidth vs Competition The other chip ...
TheraVectys SA is considering an initial public offering in Hong Kong, according to people familiar with the matter, a rare move for a non-Chinese biotech firm despite a wave of listings in the Asian financial hub. The France- and US-based immunotherapy company is working with advisers on a potential offering to raise a few hundred million dollars, the people said, asking not to be identified beca...
TheraVectys SA is considering an initial public offering in Hong Kong, according to people familiar with the matter, a rare move for a non-Chinese biotech firm despite a wave of listings in the Asian financial hub. The France- and US-based immunotherapy company is working with advisers on a potential offering to raise a few hundred million dollars, the people said, asking not to be identified because the deliberations are private. A share sale could take place as soon as this year, the people said. Considerations are ongoing and no final decisions have been made, they said. A TheraVectys representative didn’t respond to a request for comment. A Hong Kong listing by TheraVectys, led by Chief Executive Officer Ye Tian , would be unusual as non-Chinese biotech firms typically choose Europe or the US, where the industry is more developed. But China is increasingly challenging Western dominance in innovation and reshaping the biotech industry. And Hong Kong is proving attractive following a rally in biotech stocks and successful IPOs by Chinese drugmakers. About $13 billion was raised in health-care share sales in Hong Kong last year, mostly from biotech IPOs as well as follow-on offerings, data compiled by Bloomberg show. The Hang Seng Biotech Index has surged 82% in 12 months. Read More: Hengrui Pharma Prices at Top End for $1.3 Billion HK Listing A spinoff from Institut Pasteur , TheraVectys develops lentiviral vectors to prevent and treat cancer and other diseases. Its backers include Tethys Invest SAS , the investment firm of L’Oreal SA heiress Francoise Bettencourt Meyers and her family.
Novak Djokovic Severs Ties With PTPA Players' Association He Co-Founded Novak Djokovic just dropped a shocker in the world of professional tennis; he’s cutting ties with the very players’ association he helped create . Novak Djokovic, of Serbia, plays a shot against Yannick Hanfmann, of Germany, during the ATP250 tournament semifinal tennis match in Athens, Greece, Nov. 7, 2025. Thanassis Stavraki...
Novak Djokovic Severs Ties With PTPA Players' Association He Co-Founded Novak Djokovic just dropped a shocker in the world of professional tennis; he’s cutting ties with the very players’ association he helped create . Novak Djokovic, of Serbia, plays a shot against Yannick Hanfmann, of Germany, during the ATP250 tournament semifinal tennis match in Athens, Greece, Nov. 7, 2025. Thanassis Stavrakis/AP Photo The 24-time Grand Slam champion announced Sunday on X that he has stepped away completely from the Professional Tennis Players Association (PTPA) , saying his “values and approach are no longer aligned with the current direction of the organization.” I am proud of the vision that Vasek and I shared when founding the PTPA, giving players a stronger, independent voice - but it has become clear that my values and approach are no longer aligned with the current direction of the organization. — Novak Djokovic (@DjokerNole) January 4, 2026 The move marks a dramatic turn for Djokovic, who once stood front and center promoting the PTPA as a new force to represent pro players outside the sport’s traditional structure. From disruptor to dissenter Djokovic and Canadian Vasek Pospisil unveiled the idea for the PTPA at the 2020 U.S. Open, aiming to build a players’ group that could function like a union , giving athletes a powerful, unified voice in a sport where players are independent contractors and tours operate separately. The new organization was pitched as an alternative to the Association of Tennis Professionals (ATP) and Women’s Tennis Association (WTA) councils - advocating for equal representation, better pay, and greater input in decisions that affect players’ careers. In recent months, however, tensions have emerged behind the scenes. Djokovic said his decision stems from “ongoing concerns regarding transparency, governance, and the way my voice and image have been represented within the organisation.” Lawsuits, splits and strategy disputes The PTPA grabbed headl...